Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Lisata Therapeutics (LSTA) Assets Average (2016 - 2025)

Lisata Therapeutics filings provide 12 years of Assets Average readings, the most recent being $19.8 million for Q4 2025.

  • For the quarter ending Q4 2025, Assets Average fell 46.03% year-over-year to $19.8 million, compared with a TTM value of $19.8 million through Dec 2025, down 46.03%, and an annual FY2025 reading of $26.4 million, down 41.19% over the prior year.
  • Assets Average hit $19.8 million in Q4 2025 for Lisata Therapeutics, down from $23.5 million in the prior quarter.
  • The five-year high for Assets Average was $64.3 million in Q2 2023, with the low at $19.8 million in Q4 2025.
  • Median Assets Average over the past 3 years was $42.9 million (2024), compared with a mean of $42.2 million.
  • The sharpest move saw Assets Average grew 5.04% in 2024, then tumbled 46.03% in 2025.
  • Year by year, Assets Average stood at $56.4 million in 2023, then tumbled by 35.1% to $36.6 million in 2024, then plummeted by 46.03% to $19.8 million in 2025.
  • According to Business Quant data, Assets Average over the past three periods came in at $19.8 million, $23.5 million, and $27.1 million for Q4 2025, Q3 2025, and Q2 2025 respectively.